Bayer announced it successfully completed the acquisition of Monsanto on Thursday, achieving the largest acquisition in the company’s history. Shares in the U.S. company will no longer be traded on the New York Stock Exchange, with Bayer now the sole owner of Monsanto Company.

Monsanto shareholders are being paid $128 per share, or a total cost of approximately $63 billion dollars taking into account Monsanto’s debt outstanding as of February 28, 2018.

According to the conditional approval from the United States Department of Justice, the integration of Monsanto into Bayer can take place as soon as the divestments to BASF have been completed. This integration process is expected to commence in approximately two months.

“Today is a great day: for our customers – farmers around the world whom we will be able to help secure and improve their harvests even better; for our shareholders, because this transaction has the potential to create significant value; and for consumers and broader society, because we will be even better placed to help the world’s farmers grow more healthy and affordable food in a sustainable manner. As a leading innovation engine in agriculture, we offer employees around the world attractive jobs and development opportunities,” said Werner Baumann, chairman of the Bayer board of management. “Our sustainability targets are as important to us as our financial targets. We aim to live up to the heightened responsibility that a leadership position in agriculture entails and to deepen our dialogue with society.”

Hugh Grant, outgoing chairman and chief executive officers of Monsanto, commented, “Today’s closing represents an important milestone toward the vision of creating a leading agricultural company, supporting growers in their efforts to be more productive and sustainable for the benefit of our planet and consumers.”

He added, “I am proud of the path we have paved as Monsanto and look forward to the combined company helping move modern agriculture forward.”

Baumann said Monday during a conference call that the company had submitted an estimated 40 million pages of documentation to the European Commission and the U.S. Department of Justice alone in order to gain approval of the deal.

The acquisition is anticipated to generate significant value. Bayer expects a positive contribution to core earnings per share starting in 2019. From 2021 onward, that contribution is expected to be double-digit percentage. Moreover, adjusted for divestments, Bayer expects synergies to deliver annual contributions of $1.2 billion to EBITDA before special items as of 2022.

Liam Condon, member of the Bayer board of management, will lead the combined Crop Science Division when the integration commences. Until that time, Monsanto will operate independently from Bayer.

J.P. Morgan assisted Bayer with processing the purchase price payment for the largest acquisition in the company’s history.